Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.32 USD | +4.73% | +25.76% | -53.63% |
05:06pm | CASI Pharmaceuticals Gets FDA Clearance For Blood Disorder Study | MT |
05-14 | Earnings Flash (CASI) CASI PHARMACEUTICALS Posts Q1 Revenue $3.4M, vs. Street Est of $12M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.63% | 41.18M | |
+31.37% | 588B | |
-3.16% | 364B | |
+19.53% | 326B | |
+5.44% | 285B | |
+15.15% | 239B | |
+10.13% | 210B | |
-6.91% | 200B | |
+9.96% | 167B | |
-0.43% | 161B |
- Stock Market
- Equities
- CASI Stock
- News CASI Pharmaceuticals, Inc.
- BTIG Raises CASI Pharmaceuticals' Price Target to $21 From $40, Buy Rating Kept